Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space

Journal of Neuro-Oncology

Volumn 74, Issue 1, 2005, Pages 71-76

  Pan, Li Xiong ^a,b   Chen, Zhong Ping ^a   Liu, Yun Sheng ^c   Zhao, Ji Hong ^b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b DONGGUAN PEOPLE'S HOSPITAL   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Biological markers; Invasion of cavernous sinus; MRI; Pituitary adenoma

Indexed keywords

BIOLOGICAL MARKER; GADOLINIUM; GELATINASE B; KI 67 ANTIGEN; NUCLEOSIDE DIPHOSPHATE KINASE A; PROTEIN BCL 2; VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; CANCER INVASION; CAVERNOUS SINUS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOPEROXIDASE STAINING; IMMUNOREACTIVITY; MALE; MENINGEAL METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE C MYC; PREDICTION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; SURGICAL APPROACH; SURGICAL TECHNIQUE; TRANSSPHENOIDAL SURGERY; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOMA; ADOLESCENT; ADULT; CAVERNOUS SINUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NUCLEOSIDE-DIPHOSPHATE KINASE; PITUITARY NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 23944442015     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-6150-9     Document Type: Article

References (37)

1. S Wolfsberger A Ba-Ssalamah K Pinker V Mlynarik T Czech E Knosp S Trattnig 2004 Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions J Neurosurg 100: 278-286 15086236
2. J Ahmadi CM North HD Segall CS Zee MH Weiss 1985 Cavernous sinus invasion by pituitary adenomas AJNR 6: 893-898 893-898
3. JL Dietemann P Kehrli C Maillot R Diniz MR Jr C Neugroschl L Vinclair 1998 Is there a dural wall between the cavernous sinus and the pituitary fossa. Anatomical and MRI findings Neuroradiology 40: 627-630 10.1007/ s002340050653 9833890
4. N Weidner JP Semple WR Welch J Folkman 1991 Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
5. N Weidner 1996 Intratumoral vascularity as a prognostic factor in cancers of the urogenital tract. Eur J Cancer 32A: 2506-2512 10.1016/ S0959-8049(96)00378-4 9059340
6. BH Bochner RJ Cote N Weidner S Groshen SC Chen DG Skinner PW Nichols 1995 Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis J Natl Cancer Inst 87: 1603-1612 7563203
7. RE Frank TJ Saclarides S Leurgans NJ Speziale EA Drad DB Rubin 1995 Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer Ann surg 222: 695-690 8526575
8. SK Banerjee MN Zoubine TM Tran AP Weston DR Campbell 2000 Overexpression of vascular endothelial growth factor 164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells Int J Oncol 16: 253-260 10639567
9. K Maeda SM Kang N Onoda M Ogawa Y Kato T Sawada YS Chung 1999 Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma Cancer 86 566-571 10.1002/ (SICI)1097-0142(19990815)86:4<566::AID-CNCR4>3.0.CO;2-1 10440683
10. ER Sauter M Nesbit JC Watson A Klein-Szanto S Litwin M Herlyn 1999 Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck Clin Cancer Res 5: 775-782 10213212
11. HE Turner JAH Wass 1999 Are markers of proliferation valuable in the histological assessment of pituitary tumors Pituitary 1: 147-151 10.1023/ A:1009979128608 11081192
12. SC Wong JK Chan KC Lee WL Hsiao 2001 Differential expression of p16/p21/ p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumor progression in invasive ductal carcinoma of the breast J Pathol 194 35-42 10.1002/path.838 11329139
13. M Werner A Walch 2000 Morphology and biology of invasion with Barret's carcinoma as an example Verh Dtsch Ges Pathol 80: 62-68
14. DC Brown KC Gatter 1990 Monoclonal antibody Ki-67: Its use in histopathology Histopathology 17: 489-503 2076881
15. DG Wang CF Johnston AB Atkinson AP Heaney M Mirakhur KD Buchanan 1996 Expression of bcl-2 oncoprotein in pituitary tumors: Comparison with c-myc J Clin Pathol 49 795-797 8943742
16. K Knowlton M Mancini S Creason C Morales D Hockenbery BO Anderson 1998 Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect J Surg Res 76 22-26 10.1006/jsre.1998.5277 9695733
17. GJ Zhang I Kimijima T Watanabe M Kanno H Sagara Y Furukawa A Tsuchiya R Abe 1998 Correlation between apoptotic index, bcl-2 protein expression and progression and prognosis in breast carcinoma Gan To Kagaku Ryoho 25 415-421 9589045
18. PS Steeg T Ouatas D Halverson D Palmieri M Salerno 2003 Metastasis suppressor genes: Basic biology and potential clinical use Clin Breast Cancer 4 51-62 12744759
19. Y Tokunaga T Urano K Furukawa H Kondo T Kanematsu H Shilu 1993 Reduced expression of nm23-H1, but not of nm23-H2 is concordant with the frequency of lymphnode metastasis of human breast cancer Int J Cancer 55: 66-71 8102131
20. T Nakayama A Ohtsuru K Nakao M Shima K Nakata K Watanabe N Ishii N Kimura S Nagataki 1992 Expression in human hepatocellular carcinoma of nucleoside disphosphatase kinase, a homolog of the nm23 gene product J Natl Cancer Inst 84: 1349-1354 1322996
21. A Yamaguchi T Urano S Fushida K Furukawa G Nishimura Y Yonemura I Miyazaki G Nakagawara H Shiku 1993 Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis Br J Cancer 68: 1020-1024 8217591
22. LA Liotta PS Steeg WG Stetler-Stevenson 1991 Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation Cell 64: 327-336 10.1016/0092-8674(91)90642-C 1703045
23. AE Kossakowska SA Huchcroft SJ Urbanski DR Edwards 1996 Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans Br J Cancer 73 1401-1408 8645587
24. E Knosp E Steiner K Kitz CH Matula 1993 Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings Neurosurgery 33: 610-618 8232800
25. H Wakimoto M Aoyagi T Nakayama G Nagasshima S Yamamoto M Tamaki K Hirakawa 1996 Prognostic sigificance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas Cancer 77: 373-380 10.1002/ (SICI)1097-0142(19960115)77:2<373::AID-CNCR21>3.0.CO;2-Y 8625247
26. J Honegger C Prettin F Feuerhake M Petrick J Schulte-Monting M Reincke 2003 Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: Correlation with growth velocity and invasiveness J Neurosurg 99 674-679 14567602
27. CB Pizarro MC Oliveira LB Coutinho NP Ferreira 2004 Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody Braz J Med Biol Res 37: 235-243 10.1590/S0100-879X2004000200011 14762579
28. Wolfsberger S, Kitz K, Wunderer J, Czech T, Boecher-Schwarz HG, Hainfellner JA, Knosp E: Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas. Acta Neurochir (Wien). 11 [Epub ahead of print], 2004.
29. MD Berardo RM Elledge C Moor de GM Clark CK Osborne C Allred 1998 bcl-2 and apoptosis in lymph node positive breast carcinoma Cancer 82: 1296-1302 10.1002/ (SICI)1097-0142(19980401)82:7<1296::AID-CNCR12>3.0.CO;2-1 9529021
30. G Fontanini S Vignati D Bigini A Mussi M Lucchi CA Angeletti F Basolo G Bevilacqua 1995 Bcl-2 protein: A prognostic factor inversely correlated to p53 in non-small-cell lung cancer Br J Cancer 71: 1003-1007 7734290
31. M Jugenburg K Kovacs L Stefaneanu BW Scheithauer 1995 Vasculature in nontumor hypophyses, pituitary adenomas and carcinomas: A quantitative morphologic study Endocrine Pathol 6 115-124
32. HE Turner JAH Wass 1999 Are markers of proliferation useful in the histological assessment of pituitary tumors? Pituitary 1 147-151 10.1023/ A:1009979128608 11081192
33. D Gospodarowicz JA Abraham J Schilling 1989 Isolation and characterization of a vascular endothelail cell mitogen produced by pituitary-derived folliculo stellate cells Proc Natl Acad Sci USA 86: 7311-7315 2798412
34. BC Sheu HC Lien HN Ho HH Lin SN Chow SC Huang SM Hsu 2003 Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer Cancer Res 63: 6537-6542 14559848
35. M Isono R Inoue T Kamida H Kobayashi J Matsuyama 2003 Significance of leptin expression in invasive potential of pituitary adenomas Clin Neurol Neurosurg 105: 111-116 10.1016/S0303-8467(02)00129-4 12691803
36. J Trouillas L Daniel MP Guigard S Tong J Gouvernet E Jouanneau M Jan G Perrin G Fischer A Tabarin G Rougon D Figarella-Branger 2003 Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion J Neurosurg 98 1084-1093 12744370
37. YG Kong CB Su ZY Ren RZ Wang GL Li WC Dou B Zhang SQ Tian 2003 Measurement of soluble CD44v6 in peripheral blood as assistant diagnosis of invasive pituitary adenomas [Article in Chinese] Zhongguo Yi Xue Ke Xue Yuan Xue Bao 25: 698-701 14714315